Simplify Logo

Full-Time

Territory Sales Executive

Hereditary Cancers, North West

Posted on 5/30/2024

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

Data & Analytics
Hardware
AI & Machine Learning
Financial Services
Biotechnology
Healthcare

Senior

Remote in USA

Category
Strategic Account Management
Sales & Account Management
Required Skills
Sales
Marketing
Requirements
  • B.S. in life science, biology, business, or marketing - MBA preferred
  • 3+ years of direct account management experience in a molecular diagnostic setting
  • 5+ years of experience working with major cancer centers and clinics, oncology GPO’s, large health systems, IHDN’s, and large oncology practices
  • Demonstrated measurable revenue generation at a diagnostic, pharmaceutical, or relevant biotechnology company
Responsibilities
  • Drive strategic business expansion/collaboration opportunities with major U.S. cancer centers and clinics, Top 20 largest oncology practices in the territory, Key Opinion Leaders (KOLs), and Academic Medical Centers (AMCs)
  • Structure detailed strategic plans for gaining and retaining new and existing clients
  • Maximize client-bill contracting opportunities
  • Implement laboratory services agreements (LSA’s) with bill account institutions
  • Collaborate and coordinate with all sales positions to ensure successful attainment of company goals
  • Identify and develop partnering opportunities between prospective oncology clients and Tempus
  • Promote and drive compliance with new web-based molecular information tools for all clients
  • Continually analyze competitive landscape and environment within assigned accounts
  • Monitor performance of sales to ensure objectives are met
  • Develop and implement a comprehensive business plan for the territory
  • Work effectively with individuals across multiple departments throughout Tempus
  • Embrace, embody, and represent the Tempus company culture at all times to external and internal constituents

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

5%

1 year growth

12%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.
INACTIVE